Delivery Order SPE2DB25D3109-SPE2DB25FPKNB
Award Date 6/2/25
Potential Completion Date 6/24/25
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $14.7K to AmerisourceBergen Drug Corp for INGREZZA 40 mg capsules (30-count units) on September 17, 2025, with an ultimate completion date of October 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in the treatment of tardive dyskinesia, a neurological movement disorder,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of INGREZZA 40 mg capsules (30-count units) valued at $3,676.12. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 14, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat tardive dyskinesia, a...
- The Defense Logistics Agency awarded a $3,676.12 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of INGREZZA 40 mg capsules (30-count units). This is a firm fixed-price contract with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. INGREZZA is a pharmaceutical treatment used in military and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count units) under a firm fixed-price contract valued at $11,028.36. This non-competitive delivery order, issued on September 19, 2025, with completion targeted for October 10, 2025, will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat involuntary movement disorders associated with...
- The Defense Logistics Agency awarded a delivery order valued at $7,352.24 to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count units). This competitively awarded, firm fixed price delivery order is scheduled for completion by September 4, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat tardive dyskinesia, a movement disorder associated with...
- The Defense Logistics Agency awarded a $11,028.36 delivery order to AmerisourceBergen Drug Corp for INGREZZA 40 MG capsules (30-count units) on August 25, 2025, with completion expected by September 16, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,676.11 to AmerisourceBergen Drug Corp for INGREZZA 40 mg capsules (30-count units) on October 15, 2025, with an ultimate completion date of November 5, 2025. This firm fixed-price, competitively awarded contract (without set-aside designation) represents a purchase of pharmaceutical inventory to support federal medical supply requirements. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INGREZZA 80 MG capsules (30-count supply) valued at $4,027.70 under a firm fixed price contract. The award was made on September 11, 2025, with an ultimate completion date of October 2, 2025. This is a non-set-aside competitive award executed as a delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count units) under a firm fixed-price contract valued at $11,622.18. The award, issued on November 26, 2025, with an ultimate completion date of December 18, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 mg capsules (30-count) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price delivery order represents a non-competitive set-aside and will be performed at the contractor's location in Conshohocken, Pennsylvania. INGREZZA is a neurological medication used to treat tardive dyskinesia, a movement disorder associated with...